Earningsreport

Q1/2024 3/31/2024 EPS -1.310 ZacksConsensus -1.080 ActVsEst (0.230) - Miss

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx